ADXS
Price:
$0.1036
Market Cap:
$4.41M
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.
Industry
Biotechnology
IPO Date
2020-05-08
Stock Exchange
OTC
Ticker
ADXS
According to Ayala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 12.17%. This represents a change of -6865.11% compared to the average of -179.90% of the last 4 quarters.
The mean historical ROE of Ayala Pharmaceuticals, Inc. over the last ten years is -75.18%. The current 12.17% ROE has changed -16287.27% with respect to the historical average. Over the past ten years (40 quarters), ADXS's ROE was at its highest in in the December 2022 quarter at 872.43%. The ROE was at its lowest in in the June 2023 quarter at -862.14%.
Average
-75.18%
Median
-70.88%
Minimum
-276.56%
Maximum
196.88%
Discovering the peaks and valleys of Ayala Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 179.29%
Maximum Annual ROE = 196.88%
Minimum Annual Increase = -423.95%
Minimum Annual ROE = -276.56%
| Year | ROE | Change |
|---|---|---|
| 2023 | 196.88% | -423.95% |
| 2022 | -60.77% | 32.31% |
| 2022 | -45.93% | -47.63% |
| 2021 | -87.70% | -28.76% |
| 2020 | -123.10% | -55.49% |
| 2019 | -276.56% | 60.60% |
| 2018 | -172.20% | 179.29% |
| 2017 | -61.66% | 51.54% |
| 2016 | -40.68% | -49.21% |
| 2015 | -80.10% | -27.85% |
The current ROE of Ayala Pharmaceuticals, Inc. (ADXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
30.06%
5-year avg
-24.13%
10-year avg
-75.18%
Ayala Pharmaceuticals, Inc.’s ROE is greater than Health Sciences Group, Inc. (2.53%), greater than Appili Therapeutics Inc. (16.72%), greater than Algernon Pharmaceuticals Inc. (-98.85%), less than Restart Life Sciences Corp. (404.52%), greater than ReNeuron Group plc (-72.37%), greater than America Great Health (20.07%), greater than VG Life Sciences Inc. (0%), greater than Universal Ibogaine Inc. (-304.82%), greater than Regen BioPharma, Inc. (17.33%), less than Agentix Corp. (135.68%),
| Company | ROE | Market cap |
|---|---|---|
| 2.53% | $187.09K | |
| 16.72% | $1.82M | |
| -98.85% | $1.92M | |
| 404.52% | $2.27M | |
| -72.37% | $62.89K | |
| 20.07% | $2.12M | |
| 0% | $2.11M | |
| -304.82% | $2.06M | |
| 17.33% | $315.55K | |
| 135.68% | $1.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ayala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ayala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ayala Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Ayala Pharmaceuticals, Inc. (ADXS)?
What is the highest ROE for Ayala Pharmaceuticals, Inc. (ADXS)?
What is the 3-year average ROE for Ayala Pharmaceuticals, Inc. (ADXS)?
What is the 5-year average ROE for Ayala Pharmaceuticals, Inc. (ADXS)?
How does the current ROE for Ayala Pharmaceuticals, Inc. (ADXS) compare to its historical average?